• Filing Date: 2019-05-13
  • Form Type: 10-Q
  • Description: Quarterly report
v3.19.1
Stockholders' Deficiency
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Stockholders' Deficiency

5. Stockholders’ Deficiency

 

Exercise of Warrants

 

During the three months ended March 31, 2019, warrant holders exercised warrants to purchase an aggregate of 100,000 shares of common stock at a price of $0.0533 per share. In connection with these exercises, the Company received aggregate cash proceeds of $5,330 and issued 100,000 shares of common stock to the warrant holders.